Mycodern Spolka Akcyjna Logo

Mycodern Spolka Akcyjna

MCD | WAR

Overview

Corporate Details

ISIN(s):
PLMDNPL00013 (+3 more)
LEI:
25940087YXP4K8ENAO45
Country:
Poland
Address:
GDAŃSK JAŚKOWA DOLINA 132/20, 80-286 GDAŃSK
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Mycodern Spolka Akcyjna specializes in medical innovations, particularly in dermatology and fungal infection treatments. The company combines advanced research with state-of-the-art production to create effective healthcare solutions. Its commitment to addressing unmet medical needs has positioned it as a trusted name in the biotechnology industry. Mycodern aims to improve patient outcomes through innovative and accessible treatments for skin-related conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-04-08 15:20
Share Issue/Capital Change
Korekta raportu ESPI nr 4/2024 - Zakończenie emisji oraz przydział akcji serii …
Polish 2.1 KB
2024-03-29 20:50
Share Issue/Capital Change
Zakończenie emisji oraz przydział akcji serii E - Content (PL)
Polish 1.5 KB
2024-01-23 23:32
Related Party Transaction
Zawarcie ramowej umowy w zakresie wytwarzania i dostawy żelków - Content (PL)
Polish 1.2 KB
2024-01-23 23:29
Prospectus
Dokument Ofertowy - MCD
Polish 388.9 KB
2024-01-23 23:29
Report Publication Announcement
Publikacja ogłoszenia o ofercie objęcia akcji serii E przez akcjonariuszy posia…
Polish 1.2 KB
2024-01-23 17:20
Related Party Transaction
Zawarcie umowy o współpracy - Content (PL)
Polish 1.7 KB
2023-12-31 20:02
Major Shareholding Notification
zal01_Fundacja-zawiadomienie_-_art._69_ustawy_o_ofercie-29.12.2023.pdf
Polish 183.3 KB
2023-12-31 20:02
Major Shareholding Notification
zal02_MP-zawiadomienie_-_art._69_ustawy_o_ofercie-29.12.2023.pdf
Polish 181.8 KB
2023-12-31 20:02
Declaration of Voting Results & Voting Rights Announcements
Zawiadomienia akcjonariuszy w sprawie zmiany udziału w głosach - Content (PL)
Polish 637 bytes
2023-12-29 22:27
Prospectus
MCD - dokument ofertowy (seria E)
Polish 444.1 KB
2023-12-29 22:27
Report Publication Announcement
Publikacja ogłoszenia o ofercie objęcia akcji serii E przez akcjonariuszy posia…
Polish 728 bytes
2023-11-29 14:02
Prospectus
MCD - Dokument ofertowy
Polish 400.2 KB
2023-11-29 14:02
Share Issue/Capital Change
Publikacja ogłoszenia o ofercie objęcia akcji serii E przez akcjonariuszy posia…
Polish 1.5 KB
2023-10-23 21:09
Share Issue/Capital Change
Formularz zapisu - seria E
Polish 168.3 KB
2023-10-23 21:09
Prospectus
Dokument Ofertowy - seria E
Polish 353.1 KB

Automate Your Workflow. Get a real-time feed of all Mycodern Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Mycodern Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
OPTIBIOTIX HEALTH PLC Logo
Develops microbiome-modulating ingredients and supplements to manage chronic lifestyle diseases.
United Kingdom OPTI
OXFORD BIODYNAMICS PLC Logo
Develops precision blood tests using 3D genomics for cancer diagnosis and therapy guidance.
United Kingdom OBD
Pharnext Logo France ALPHA
PHYSIOMICS PLC Logo
De-risks oncology drug development for pharma/biotech using modeling and simulation.
United Kingdom PYC
PILA PHARMA AB Logo
Clinical-stage biopharma developing a first-in-class oral drug for diabetes and obesity.
Sweden PILA
POOLBEG PHARMA PLC Logo
AI-led biopharma developing drugs for high-need diseases like CRS and metabolic disorders.
United Kingdom POLB
PROTEOME SCIENCES PLC Logo
CRO providing proteomics services & TMT® tags to biopharma for drug discovery & biomarkers.
United Kingdom PRM
PROVEXIS PLC Logo
Develops & licenses Fruitflow®, a patented ingredient for heart health in food & supplements.
United Kingdom PXS
Develops uncopiable atomic fingerprints for anti-counterfeiting, verifiable by smartphone.
United Kingdom N/A
QUANTUM BLOCKCHAIN TECHNOLOGIES PLC Logo
R&D firm using AI and quantum computing to create efficient technologies for Bitcoin mining.
United Kingdom QBT

Talk to a Data Expert

Have a question? We'll get back to you promptly.